ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Dec 11, 2012
Inside AbbVie: A Look at a New Pharmaceutical Giant
Let's take a look at Abbott's new standalone business, AbbVie.
Dec 10, 2012
Modest Valuation Upside Remains at Phillips 66
A higher dividend and new share repurchase authorization could help propel shares of the refiner.
Dec 10, 2012
Nelson Peltz Shakes Up Ingersoll Rand
A spinoff, buyback, and increased dividend were all announced today at Ingersoll Rand. We take a look at the new developments.
Dec 10, 2012
Is McDonald’s Back on Track?
November same-store sales increased at a better-than-expected rate, but has the fast food retailer returned to growth? We provide our take.
Dec 7, 2012
Enbridge Capitalizes on Fantastic Shale Oil Growth
Enbridge remains on track to grow its dividend going forward. We like the firm’s dividend, but think its shares are fairly valued.
Dec 7, 2012
Dividends at Financial Services Firms
We take a look at dividends from a few well-known firms in one of the hardest hit sectors of the Great Recession.
Dec 6, 2012
Lululemon’s Growth Hasn’t Stalled
Lululemon reported a solid third quarter, with earnings, revenue, and cash increasing at a rapid clip. Could Nike be interested?
Dec 6, 2012
Freeport McMoRan Following the BHP Model
Freeport McMoRan diversifies by reacquiring McMoRan Oil & Gas and Plains Exploration.
Dec 5, 2012
Inside Intel’s Debt Offering
Intel has plenty of cash and liquidity, but it will go to the debt markets to raise $6 billion in new capital. Let's examine why.
Dec 5, 2012
Auto Parts Retailers Feeling the Auto Recovery
Auto parts retailers are starting to feel the auto recovery, but it doesn’t feel good.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.